MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A - Test2 - elhamkhani - TriplyDB

MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A

MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A

http://www.wikidata.org/entity/Q35550210

about

The PTEN tumor suppressor gene and its role in lymphoma pathogenesis MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer.MicroRNA Expression Profile of Neural Progenitor-Like Cells Derived from Rat Bone Marrow Mesenchymal Stem Cells under the Influence of IGF-1, bFGF and EGF.Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition.JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells.MicroRNA-223 Expression is Upregulated in Insulin Resistant Human Adipose Tissue MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma.miR-382 targeting PTEN-Akt axis promotes liver regeneration Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2.MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide.MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis.MicroRNA-93-5p may participate in the formation of morphine tolerance in bone cancer pain mouse model by targeting Smad5.Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of LKB1/PTEN/CDKN1A.Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma.MicroRNA-93 inhibits apoptosis and promotes proliferation, invasion and migration of renal cell carcinoma ACHN cells via the TGF-β/Smad signaling pathway by targeting RUNX3.miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.Upregulation of PREX2 promotes the proliferation and migration of hepatocellular carcinoma cells via PTEN-AKT signaling.Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint.Trends in the development of MET inhibitors for hepatocellular carcinoma.Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.The roles of microRNAs related with progression and metastasis in human cancers.Emerging Role of MicroRNAs in mTOR Signaling.Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors.Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2.MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma.Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1.miRNAs as potential regulators of mTOR pathway in renal cell carcinoma.Regulation of the tumor suppressor PTEN by natural anticancer compounds.MiR-93-5p Promotes Cell Proliferation through Down-Regulating PPARGC1A in Hepatocellular Carcinoma Cells by Bioinformatics Analysis and Experimental Verification.

P2860

Q26776527-CFB77D00-9CFE-479A-8208-117874A68607 Q33724136-7525A995-517A-4030-8DF4-921E51DF10CA Q33750953-7DF4AF11-D7D3-4559-9405-F57815E5F2E3 Q35722985-34AEE406-DE40-4272-808B-7D6834DA24F2 Q35823330-AA076168-27C5-4EBF-BAE0-394173072030 Q35828666-6726642B-55BF-422F-B7F6-BDA4AAEFB5EF Q35914705-2A24BBEF-424F-4754-A115-2AE80D4BBFC9 Q35932403-8D86A04A-1111-4133-9274-F9C7AB81EFBB Q36428863-E87026FB-14CB-4BC3-BCDF-167881A5DBE8 Q36464350-065C7160-18AF-4F45-AF98-12F8E8C442EF Q36557155-07488F3B-9EEA-433E-BCA9-04C0D38165BE Q36557527-28F944ED-414E-45C0-B1F3-6D02102F1EC0 Q36736286-A6304091-20B0-45FD-B4FF-2AEE5FDDCCA2 Q36738912-ECA13AC2-7F4B-4CAD-9960-8E5A93DE3381 Q36766823-C925B031-5335-4584-A3C9-B32EB663DD22 Q37036256-0925714F-5322-466E-8DBB-0D78FDC36185 Q37109724-B52FC201-3068-4903-AF72-2536C95BD849 Q37215410-2955587F-E1F3-4483-A159-E67B838D056C Q37588418-FA477B1D-7242-44F2-A749-0EF18EE8F277 Q37694781-AF898E36-31A7-491C-A5D4-89D8A484C652 Q37738099-6C8AC045-1C18-4006-9D16-226C201B557C Q38585471-CE209594-BF32-4F46-BE65-8A3E17553085 Q38695006-6422CE03-52AC-4418-91AA-DBABF89BBDDD Q38714556-2BD708EE-179F-47C7-A379-0C7084411994 Q38721192-124AC504-EEC1-4B48-9F7C-C872E0A9CD7D Q38748101-A403E77C-373C-4584-B42F-F6F7217CECB6 Q38777675-E4174E85-447F-44A6-BDB9-C13F29D6DEE9 Q38847201-ED9335C4-5EF2-41D3-894D-646CCE2F8184 Q38974714-0AC39684-E229-4F53-AEFE-0D7114B211C8 Q39151248-12FC452D-599F-4DFE-902E-232FD3BA1079 Q41127791-3A66E816-E254-4B50-90E7-528AF732BE6E Q43053966-3FCB08FA-8AEF-4AC5-A3BE-54A1AE2C952F Q47096853-A98E7296-EFBF-45CE-AC62-DB50F9998A84 Q47140045-03CC955A-C469-4F3B-98C2-9E7A946C7DC2 Q47142430-8CBC3434-109F-4AEA-B736-BBA1E3CF675E Q47191085-CEE9AC8F-7583-4BC2-8426-F2C6F9C5CA6D Q47548532-74C10821-FA90-4B9B-9595-4B4E7D3016E2 Q47553641-4D282362-038E-46ED-A518-982F6A183EC4 Q47691876-D9B8A8CA-6860-4A1F-80BA-A1C8C453B83D Q47716490-DF9C9F2A-D0D7-4295-98A4-693497D73082

P2860

MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A

http://www.wikidata.org/entity/Q35550210

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

MicroRNA-93 activates c-Met/PI ...... tly inhibiting PTEN and CDKN1A

@ast

MicroRNA-93 activates c-Met/PI ...... tly inhibiting PTEN and CDKN1A

@en

type

label

MicroRNA-93 activates c-Met/PI ...... tly inhibiting PTEN and CDKN1A

@ast

MicroRNA-93 activates c-Met/PI ...... tly inhibiting PTEN and CDKN1A

@en

prefLabel

MicroRNA-93 activates c-Met/PI ...... tly inhibiting PTEN and CDKN1A

@ast

MicroRNA-93 activates c-Met/PI ...... tly inhibiting PTEN and CDKN1A

@en

P1433

Q35550210-B55AA699-2208-426F-910D-A5E1316C52E0

P1476

Q35550210-DA2563D9-4807-4F2D-8CF7-0019897BC75F

P2093

Q35550210-05F1C445-862A-4826-BB9E-B5934D90A53A

Q35550210-31D26E14-BBC7-46D8-AB93-723D8E9E4D2B

Q35550210-38E71779-477A-45F1-87E6-200CD49EEDC3

Q35550210-44C1558B-40E6-49AC-8144-757C1C6A0410

Q35550210-5BF696B5-4C40-4E3A-BCCC-675D8049BAB3

Q35550210-DEEEE1FF-B21B-494D-9D77-C320B61D4E7E

Q35550210-EE588D2B-DBC9-4669-B7A9-D826D3E9BAD7

P2860

Q35550210-050A5CCF-C053-4240-81B8-7AFBAC5CA9EC

Q35550210-0EF5DF47-D64C-489C-9BA1-A27D8F8E87D7

Q35550210-1472B415-D659-4FF8-85B6-BF3965BEA4F1

Q35550210-23F0376A-3ABD-48D9-93C7-837E3C9A6127

Q35550210-33B2789C-74CF-4575-9711-03700A8EC85B

Q35550210-3E9FF842-D7AC-47C4-9347-BD259D23C127

Q35550210-3ED4A713-8AA0-4C97-8848-8A07A435E217

Q35550210-40879DBF-8D4C-4DD6-B270-911D63A290AB

Q35550210-49B87031-3A8D-4E5A-86F5-097542A59167

Q35550210-646211BA-E051-4E78-BC06-52B9AB9AB6DF

P304

Q35550210-C804255E-8F7A-42C1-AF1F-30AE0DE0F26B

P31

Q35550210-6993EC9C-A31F-4A0B-B3E4-6372E24EBD44

P356

Q35550210-268F4BE2-9FA5-4FB7-B9F9-167C00651E51

P407

Q35550210-84C01EA9-A0F6-45ED-8F85-0676AEB4B236

P433

Q35550210-E63844ED-22F6-4602-A395-3027D4A577BC

P478

Q35550210-9CF26458-1808-4A01-BD43-5BCBB13641A1

P50

Q35550210-AFB7B537-465F-4EEA-9309-4D8D9F9E6B07

Q35550210-BEF69539-CC93-4F74-BEB1-619448D49F9D

P577

Q35550210-F6D4392D-65DE-4A33-993B-48681ED6A4D8

P5875

Q35550210-913DC324-F460-4C8B-92DB-F6BFA578C697

P698

Q35550210-8E5183FE-590C-4B4A-89C4-39D23C732A2F

P921

Q35550210-3DA969CB-4D02-4F97-B8D6-AFBEABFA68F7

P932

Q35550210-A76008EE-8668-48C1-9BA9-FA664E16A804

P356

ONCOTARGET.3085

P1433

P1476

MicroRNA-93 activates c-Met/PI ...... tly inhibiting PTEN and CDKN1A

@en

P2093

Hiromitsu Hoshino

http://www.w3.org/2001/XMLSchema#string

Jinhua Wang

http://www.w3.org/2001/XMLSchema#string

Katsuya Ohta

http://www.w3.org/2001/XMLSchema#string

Sharon K Huang

http://www.w3.org/2001/XMLSchema#string

Shigeshi Ono

http://www.w3.org/2001/XMLSchema#string

Steven Colquhoun

http://www.w3.org/2001/XMLSchema#string

Yuuki Iida

http://www.w3.org/2001/XMLSchema#string

P2860

The microRNA-30 family is required for vertebrate hepatobiliary development

In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

MicroRNAs: genomics, biogenesis, mechanism, and function

Sorafenib in advanced hepatocellular carcinoma

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

P304

3211-3224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3085

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271594098

http://www.w3.org/2001/XMLSchema#string

P698

25633810

http://www.w3.org/2001/XMLSchema#string

P921

P932

4413648

http://www.w3.org/2001/XMLSchema#string